Chemoinformaics analysis of 13-nor-Eudesm-4,6-dien-11-one
| Molecular Weight | 204.313 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 25 |
| Exact Molecular Weight | 204.151 | nRing | 2 |
| Solubility: LogS | -3.044 | nHRing | 0 |
| Solubility: LogP | 2.394 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 37.5179 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.844 |
| Synth | 5.058 |
| Natural Product Likeliness | 1.319 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.022 |
| Pgp-sub | 0.063 |
| HIA | 0.007 |
| CACO-2 | -4.885 |
| MDCK | 0.0000199 |
| BBB | 0.992 |
| PPB | 0.771425 |
| VDSS | 2.337 |
| FU | 0.207194 |
| CYP1A2-inh | 0.125 |
| CYP1A2-sub | 0.946 |
| CYP2c19-inh | 0.483 |
| CYP2c19-sub | 0.925 |
| CYP2c9-inh | 0.048 |
| CYP2c9-sub | 0.831 |
| CYP2d6-inh | 0.919 |
| CYP2d6-sub | 0.915 |
| CYP3a4-inh | 0.812 |
| CYP3a4-sub | 0.858 |
| CL | 15.651 |
| T12 | 0.475 |
| hERG | 0.051 |
| Ames | 0.04 |
| ROA | 0.923 |
| SkinSen | 0.065 |
| Carcinogencity | 0.679 |
| EI | 0.021 |
| Respiratory | 0.934 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.758501 |